Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study
Wei Liu(Capital Medical University), Dong Zhang(Capital Medical University), Xingju Liu(Capital Medical University), Xun Ye(Capital Medical University), Yuanren Zhai(Capital Medical University), Xiaofan Yu(Capital Medical University), Qiheng He(Capital Medical University), Qian Zhang(Brigham and Women's Hospital), Yan Zhang(Beijing Tian Tan Hospital), Junsheng Li(National Clinical Research Center for Digestive Diseases), Chenglong Liu(Capital Medical University), Rong Wang(Yinchuan First People's Hospital), Peicong Ge(Capital Medical University)
Cited by 14
Related Papers
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
Soluble dietary fiber and polyphenol complex in lotus root: Preparation, interaction and identification
|Food Chemistry|2020|72
Glypican-1 antisense transfection modulates TGF-β-dependent signaling in Colo-357 pancreatic cancer cells
|Biochemical and Biophysical Research Communications|2004|57
Characteristics of cognitive impairment in adult asymptomatic moyamoya disease
|BMC Neurology|2020|39
Identification of N6-methyladenosine-related lncRNAs for patients with primary glioblastoma
|Neurosurgical Review|2020|37